UCRF Competitive Grants Program 2013 Innovation Awards were chosen from 51 applications. The awards provided $1,180,000 to support research among the six winners.
Abstracts of the award winners can be read at the Innovation Awards website. The recipients are as follows:
W. Kimryn Rathmell (MD, PhD, Medicine, Genetics) – “Exploiting DLL4 Inhibition as a Mechanism to Overcome Antiangiogenic Resistance in ccRCC”
Timothy Gershon (MD, PhD, Neurology) – “Developmental Origins of Therapeutic Response in Medulloblastoma”
Timothy Elston (PhD, Pharmacology) – “Defining the Genomic and Epigenomic Plasticity of Basal and Claudin-low Breast Cancer”
Ronald Chen (MD, MPH, Radiation Oncology) – “Building and Characterizing the North Carolina Bladder Cancer Cohort: Defining Quality of Life and Potential Health Care Needs During Survivorship”
Federico Innocenti (MD, PhD ,UNC Eshelman School of Pharmacy) – A Phase II UGT1A1 Genotype-guided Study of Irinotecan in Metastatic Colorectal Cancer Patients Receiving FOLFIRI + Bevacizumab
Maureen Su (MD, Pediatrics, Microbiology & Immunology) – “Autoimmune Regulator as a Genetic Determinant of Ipilimumab Response in Melanoma”
Date: July 23, 2013